Aryl dihydropyridinones and piperidinone MGAT2 inhibitors
申请人:BRISTOL-MYERS SQUIBB COMPANY
公开号:US10369140B2
公开(公告)日:2019-08-06
The present invention provides compounds of Formula (I):
or a stereoisomer, or a pharmaceutically acceptable salt thereof, wherein all of the variables are as defined herein. These compounds are monoacylglycerol acyltransferase type 2 (MGAT2) inhibitors which may be used as medicaments.
ARYL DIHYDROPYRIDINONES AND PIPERIDINONE MGAT2 INHIBITORS
申请人:BRISTOL-MYERS SQUIBB COMPANY
公开号:US20180133198A1
公开(公告)日:2018-05-17
The present invention provides compounds of Formula (I):
or a stereoisomer, or a pharmaceutically acceptable salt thereof, wherein all of the variables are as defined herein. These compounds are monoacylglycerol acyltransferase type 2 (MGAT2) inhibitors which may be used as medicaments.
作者:Robin B. Bedford、Jens U. Engelhart、Mairi F. Haddow、Charlotte J. Mitchell、Ruth L. Webster
DOI:10.1039/c0dt00385a
日期:——
The solvent-free, palladium-catalysed reaction of anilides with CuCl2 in the presence or absence of copper acetate yields ortho-chlorinated anilides in good to excellent yields, even on a large scale (100 mmol). By contrast, the equivalent reactions with copper bromide, either solvent free or in 1,2-dichloroethane, in the presence or absence of palladium, under air or inert conditions, gave the products